Eagle Capital Growth Fund (GRF) Stock Price, News & Analysis

Company Overview

Eagle Capital Growth Fund, Inc. is a closed-end equity mutual fund launched and managed by Sims Capital Management LLC. The fund invests in the public equity markets of the United States. It makes its investments in the stocks of companies operating across diversified sectors. The fund benchmarks the performance of its portfolio against the S&P 500 Index. It was previously known as NAIC Growth Fund, Inc. Eagle Capital Growth Fund, Inc. was formed on April 11, 1989 and is domiciled in the United States.

Key Stats

• Today's Range: $9.74 to $9.81
• 50-Day Range: $9.15 to $9.90
• 52-Week Range: $8.85 to $11.24
• Volume: 3,035 shs
• Average Volume: 4,469 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 5.20%
• Price Target: N/A
• Consensus Rating: N/A

GRF Stock Analysis - Frequently Asked Questions

How have GRF shares performed this year?

Eagle Capital Growth Fund's stock was trading at $9.82 at the beginning of 2025. Since then, GRF shares have decreased by 0.1% and is now trading at $9.8090.
View the best growth stocks for 2025 here.

Who are Eagle Capital Growth Fund's major shareholders?

Eagle Capital Growth Fund's top institutional shareholders include Sigma Investment Counselors Inc.. Insiders that own company stock include Luke E Sims, David C Sims and Donald G Tyler.
View institutional ownership trends.

How do I buy shares of Eagle Capital Growth Fund?

Shares of GRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Eagle Capital Growth Fund own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Eagle Capital Growth Fund investors own include Advanced Emissions Solutions (ADES), Extendicare (EXE), Altaba (AABA), Abeona Therapeutics (ABEO), Achaogen (AKAO), Allegiant Travel (ALGT) and Amneal Pharmaceuticals (AMRX).

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Financial Services
• Current Symbol: NYSEAMERICAN:GRF
• Previous Symbol: NYSEMKT:GRF
• CIK: 850027
• Web: www.eaglecapitalgrowthfund.com
• Phone: (414) 765-1107
• Fax: N/A
• Employees: 14,890
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A